Experimental studies using different cancer derived cell lines from human bladder, breast and prostate tumor, showed that reintroduction of LZTS1 results in inhibition of tumor cell growth in vitro and/or tumorigenicity in vivo. The gene discussed is LZTS1; the disease is cancer.